Defensive Pricing and Patent Litigation Are Favored Counter-Generics Strategies, for Now

Short-term strategies, such as patent litigation and defensive pricing, have been the most popular counter-generics tactics for pharmaceutical brand teams to pursue in the last four years, according to research from Cutting Edge Information. 57 percent of brand teams facing generic copies implement defensive pricing strategies, while 60 percent pursue patent litigation. Both strategies can be initiated within the last...